Baxter Healthcare Corporation vs Novel Laboratories, Inc. d.b.a Lupin Somerset: FDA Enforcement Comparison

Baxter Healthcare Corporation has been the subject of 208 FDA enforcement/approval records tracked by Argus HQ, compared to 1 for Novel Laboratories, Inc. d.b.a Lupin Somerset.

Baxter Healthcare Corporation: 0 warning letters, 208 recalls, 0 approval records, 0 Form 483s.

Novel Laboratories, Inc. d.b.a Lupin Somerset: 0 warning letters, 0 recalls, 0 approval records, 1 Form 483.

Side by side

Baxter Healthcare Corporation — Warning letters0

Novel Laboratories, Inc. d.b.a Lupin Somerset — Warning letters0

Baxter Healthcare Corporation — Recalls208

Novel Laboratories, Inc. d.b.a Lupin Somerset — Recalls0

Baxter Healthcare Corporation — Approval records0

Novel Laboratories, Inc. d.b.a Lupin Somerset — Approval records0

Baxter Healthcare Corporation — Form 483s0

Novel Laboratories, Inc. d.b.a Lupin Somerset — Form 483s1

Timeline

Baxter Healthcare Corporation

Most recent FDA action: July 8, 2026

Full history →

Novel Laboratories, Inc. d.b.a Lupin Somerset

Most recent FDA action: April 17, 2026

Full history →

Cite this comparison

Pre-formatted for a story, footnote, or reference list:

"Baxter Healthcare Corporation vs Novel Laboratories, Inc. d.b.a Lupin Somerset: FDA Enforcement Comparison." Argus HQ, accessed August 17, 2026. https://argushq.ai/compare/baxter-healthcare-corporation-vs-novel-laboratories-inc-d-b-a-lupin-somerset

Source: FDA.gov (aggregated across Warning Letters, Recalls, Approvals, Form 483s) ↗